Tag Archives: Chronic Pain

Study: Medical Cannabis Treatment Significantly Reduces Chronic Pain in Elderly

Study: Medical Cannabis Treatment Significantly Reduces Chronic Pain in Elderly

Study: Medical Cannabis Treatment Significantly Reduces Chronic Pain in Elderly

Baby boomers have become a growing market segment in the legal cannabis industry as the acceptance of medical cannabis treatment continues to spread across the world, and now it appears that medical cannabis treatment may offer senior citizens a safer alternative to opioids in the treatment of chronic pain.

GrowPros

Tetra Bio-Pharma Receives Health Canada Approval for Phase 2 Cannabis Oil Trial in Partnership with Sante Cannabis

OTTAWA, Ontario, Jan. 29, 2018 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce the approval by Health Canada of a Phase 2 clinical trial designed to evaluate the safety and efficacy of different doses and ratios of medical cannabis oil (THC & CBD) to improve uncontrolled chronic pain in cancer and non-cancer patients.

Illinois Judge: Add Chronic Pain as Qualifying Condition for Medical Marijuana

Illinois Judge: Add Chronic Pain as Qualifying Condition for Medical Marijuana

Illinois patients suffering from chronic pain may soon have a new way to treat their medical condition. On Jan. 16, 2018, Cook County Judge Raymond Mitchell ordered the Illinois Department of Public Health to add chronic pain as a qualifying condition for the state’s medical marijuana program.

VA Says It Won't Study Medical Marijuana's Effect on Veterans

VA Says It Won’t Study Medical Marijuana’s Effect on Veterans

The Department of Veterans Affairs says it will not conduct research into whether medical marijuana could help veterans suffering from post-traumatic stress disorder and chronic pain, as veterans groups are pushing for the use of the drug as an alternative to opioids and anti-depressants.

West Virginia Medical Cannabis Interests 82 Percent of Doctors in State

West Virginia Medical Cannabis Interests 82 Percent of Doctors in State

Medical cannabis cards in the Mountain State won’t see the light of day until July 1, 2019, but it appears prospective patients might have an easier time finding a West Virginia medical cannabis doctor.

Minnesota Medical Marijuana Patients Struggle to Deal With Supply Shortage

Minnesota Medical Marijuana Patients Struggle With Supply Shortage

Minnesota medical marijuana patients are worried after news broke that one of the state’s two cannabis providers is experiencing a distribution delay, leaving them with scarce supplies for treatment.

DayaCann AusCann Group Holdings - Medical Liaison Managers placement Tasmanian Alkaloids and Chilean License

Chilean Cultivation Licence Secured for Second Crop

CARABOODA, Western Australia, Nov. 22, 2017 /Weed Wire/ — AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’) is pleased to announce that its joint venture (JV) in Chile, DayaCann, has secured a further licence for the cultivation of medical cannabis crops at its Chilean facility.

Lawmakers: Feds Should Research Medical Marijuana for Military Vets

Lawmakers: Feds Should Research Medical Marijuana for Military Vets

A group of 10 U.S. House members is pushing the Trump administration to begin researching medical marijuana’s potential benefits for military veterans struggling to cope with war wounds.

Why NJ Patients With Chronic Pain Still Can't Get Medical Marijuana

Why NJ Patients With Chronic Pain Still Can’t Get Medical Marijuana

Five months ago, a New Jersey health panel voted in favor of dramatically expanding the list of conditions that may be treated with cannabis. Chronic pain, Alzheimer’s, autism, anxiety, migraines, and other maladies should be added to the list of 13 ailments, said the panel of doctors and other health professionals.

American Pain Society

American Pain Society Supports Passage of Marijuana Effective Studies Act

CHICAGO, Sept.18, 2017 /Weed Wire/ – A bipartisan group of senators led by Brian Schatz (D-Hawaii) has reintroduced the Marijuana Effective Studies Act of 2016 (MEDS Act), which will remove excessive regulatory barriers inhibiting researchers from obtaining marijuana plants to conduct studies assessing the drug’s medical effectiveness and safety.

Little Evidence Shows Cannabis Helps Chronic Pain or PTSD

Little Evidence Shows Cannabis Helps Chronic Pain or PTSD

Even though pain and posttraumatic stress disorder (PTSD) are among the most common reasons people use medical marijuana in the U.S., there isn’t much proof cannabis works for either one of these conditions, two research reviews suggest.

This Is the First Long-Term Study on Cannabis and Opioids for Chronic Pain

This Is the First Long-Term Study on Cannabis and Opioids for Chronic Pain

On Aug. 8, 2017, Albert Einstein College of Medicine and Montefiore Health System announced that they had received a grant from the National Institutes of Health to conduct a long-term study on how medical cannabis affects opioid use in adults with chronic pain.

First Long-Term Study on Medical Marijuana's Impact on Opioid Use for Pain

First Long-Term Study on Medical Marijuana’s Impact on Opioid Use for Pain

BRONX, N.Y., Aug. 8, 2017 /Weed Wire/ — The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine and Montefiore Health System a five-year, $3.8 million grant for the first long-term study to test whether me

New Eligible Conditions Recommended By New Jersey Medicinal Marijuana Panel

New Jersey Medicinal Marijuana Panel Recommends New Qualifying Conditions

On July 25, 2017, the New Jersey Medicinal Marijuana Program Review Panel revealed an initial recommendation to add migraines, Tourette’s Syndrome, chronic pain and anxiety to the list of qualifying conditions for those seeking medical marijuana treatment in the Garden State.

New Jersey Medicinal Marijuana Review Panel Recommends Adding Chronic Pain, Migraine, Anxiety and Tourette's Syndrome to List of Qualifying Conditions

New Jersey Medicinal Marijuana Review Panel Recommends Adding Chronic Pain, Migraine, Anxiety and Tourette’s Syndrome to List of Qualifying Conditions

Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain, migraine, anxiety and Tourette’s Syndrome as qualifying conditions for the medical marijuana program.

Greece CMD Was Published for the Introduction of Approved Medications and Cannabis Products

ATHENS, Greece, June 30, 2017 /Weed Wire/ — Published today in the Official Gazette, Joint Ministerial Decision (JMD) Ministers of Health and Justice, which opens the way for the introduction of approved medications and hemp products. These formulations are indicated for cases that have proven clinical benefit for a variety of diseases such as chronic pain, neuropathic pain, nausea and vomiting due to chemotherapy, cachexia / anorexia. etc.

Axim Biotech - MedChew Rx

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

NEW YORK, June 23, 2017 /Weed Wire/ — AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with the United States Patent and Trademark Office (USPTO) for U.S. Application Serial Number 62/410,469, a patent of invention that involves a chewing gum composition with controlled release of cannabinoids and opioid agonists and/or antagonists for addiction and/or dependence treatment.

NYSDOH regulations Announces Chronic Pain to Be Added As Qualifying Condition for Medical Marijuana Enhancements, New Registered Organizations

New York State Department of Health Announces Enhancements to Medical Marijuana Program

ALBANY, N.Y., June 22, 2017 /Weed Wire/ – The New York State Department of Health (NYSDOH) today announced several new enhancements to the state’s Medical Marijuana Program as the number of certified patients continues to rise since the addition of chronic pain as a qualifying condition.

Aclara Research - preliminary results

Aclara Research Leads Medical Cannabis Industry with Release of Largest Illinois Patient Study

CHICAGO, Ill., May 23, 2017 /Weed Wire/ — Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study – the first of Illinois patients since the inception of the pilot program in 2012.

city council

New Jersey Medicinal Marijuana Review Panel Recommends Adding Chronic Pain and other Conditions to List of Qualifying Conditions

TRENTON, N.J., May 11, 2017 /Weed Wire/ — Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain related to musculoskeletal disorders, migraines, anxiety, chronic fatigue related to ailments such as irritable bowel syndrome, Tourrette syndrome as qualifying conditions for the medical marijuana program.

NYSDOH regulations Announces Chronic Pain to Be Added As Qualifying Condition for Medical Marijuana Enhancements, New Registered Organizations

New York State Department of Health Adds Thousands of New Patients to Medical Marijuana Program Following the Addition of Chronic Pain

ALBANY, New York, May 5, 2017 /Weed Wire/ — The New York State Department of Health today announced several milestones in the state’s Medical Marijuana program, including the certification of more than 3,350 patients since the addition of chronic pain as a qualifying condition in late March.

Study: Canadian Patients Substituting Marijuana for Prescription Drugs

Study: Canadian Patients Substituting Marijuana for Prescription Drugs

According to a study recently published by the International Journal of Drug Policy, patients in Canada are substituting marijuana for opioids, benzodiazepines and antidepressants for symptom relief from pain and mental health conditions.

NJ Patients beg treat pain with MMJ

NJ Patients Beg: Treat Pain With Medical Marijuana Instead of Opioids

As Gov. Chris Christie travels the state on an aggressive campaign to end an epidemic of heroin and prescription drug overdoses, more than two dozen New Jersey citizens came to the capital city Wednesday to offer him a new strategy.

New Study Makes Comprehensive Review of Scientific Health Data on Marijuana

New Study Makes Comprehensive Scientific Review of Health Data on Pot

The National Academics of Sciences, Engineering and Medicine has released a 395-page report that looks at a wide range of scientific evidence on the effectiveness of marijuana as medicine. “The Health Effects of Cannabis and Cannabinoids” provides “a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis.”

NYSDOH regulations Announces Chronic Pain to Be Added As Qualifying Condition for Medical Marijuana Enhancements, New Registered Organizations

NYSDOH Announces Ability for Wholesaling of Medical Marijuana Products and Removes Cap On Number of Products Available to Patients

ALBANY, N.Y., Dec. 8, 2016 /Weed Wire/ — The New York State Department of Health today announced several enhancements to the state’s Medical Marijuana Program that will improve access for patients, streamline production, increase choice and help lead to reduced costs.

opioid

New Study Suggests Medical Marijuana Could be The Answer to Opioid Crisis

A new study suggests legalized medical marijuana could be the answer to the ongoing opioid crisis in the United States, according to a Sept. 17, 2016, article at The Huffington Post. The study examined traffic fatalities in 18 states 1999-2013. Researchers noticed states with legalized medical marijuana saw a drop in accidents in which the driver had been taking an opioid.

Opioids

Legal Cannabis Means Fewer Opioid Deaths

It has been 15 years since the advent of medical marijuana in the United States. A new study published by JAMA Internal Medicine sought to determine the effect the availability of legal medical marijuana has on the rate of opioid overdoses in states where patients have access to medical marijuana.


Top